By Counterforce Health Team in Dojolvi (triheptanoin) —

If Dojolvi (Triheptanoin) Isn't Approved by Cigna in Georgia: Formulary Alternatives & Exception Paths

Answer Box

If Cigna denies Dojolvi (triheptanoin) coverage in Georgia, you have three main paths: 1) Try formulary alternatives like MCT oil supplementation under specialist guidance, 2) Request a formulary exception with medical necessity documentation, or 3) File an external review through the Georgia Department of Insurance within 60 days. Most LC-FAOD patients start with MCT oil as step therapy before Dojolvi approval. Your first step today: contact your metabolic specialist to document prior MCT oil trials and gather genetic testing results for a formulary exception request.

Table of Contents

When Alternatives Make Sense

Cigna typically requires step therapy for long-chain fatty acid oxidation disorders (LC-FAOD), meaning you'll need to try covered alternatives before Dojolvi approval. This approach makes clinical sense in many cases, as MCT oil therapy can effectively manage symptoms for patients with mild to moderate LC-FAOD.

Consider alternatives when:

  • You have a new LC-FAOD diagnosis without prior treatment history
  • Your symptoms are mild and occur only during fasting or increased energy demands
  • You haven't documented adequate trials of standard therapies
  • Cost considerations are important while building your appeal case

However, alternatives may not be appropriate if you have:

  • Severe LC-FAOD with recurrent metabolic crises
  • Documented MCT oil intolerance or contraindications
  • Cardiomyopathy or other complications requiring specialized therapy
  • Failed multiple standard treatments under specialist care

Typical Formulary Alternatives

Medium-Chain Triglyceride (MCT) Products

MCT Oil (Primary Alternative) Most insurers, including Cigna, cover prescription MCT oil products like MCT Oil® or Liquigen® as first-line therapy. MCTs provide accessible energy without accumulating toxic metabolic byproducts, making them effective for many LC-FAOD patients.

MCT Powder Formulations MCT Procal™ and similar powder forms offer easier mixing for patients who struggle with oil consistency. These are typically covered under durable medical equipment benefits.

Supportive Therapies

L-Carnitine Supplementation L-carnitine is indicated for patients with low carnitine levels and may provide complete symptom relief in carnitine transporter deficiency. Most plans cover generic L-carnitine formulations.

DHA Supplementation All LC-FAOD patients should receive preformed DHA supplementation at specific dosages based on weight. This is typically available over-the-counter or through prescription.

Essential Fatty Acid Supplements Walnut or flaxseed oil supplementation prevents essential fatty acid deficiency in patients on restricted long-chain fat diets.

Pros and Cons Overview

MCT Oil Therapy

Advantages:

  • Widely covered by insurance with minimal prior authorization
  • Established safety profile in LC-FAOD management
  • Can reverse cardiomyopathy in conditions like VLCADD and CACTD
  • Lower cost compared to Dojolvi ($5,857–$6,365 per bottle)
  • Flexible dosing and administration options

Limitations:

Investigational Options

Bezafibrate is under investigation for LC-FAOD treatment, showing varying results in clinical trials. However, this remains experimental and typically isn't covered for LC-FAOD indications.

Exception Strategy

When to Request an Exception

File a formulary exception request when:

  • You've completed an adequate trial of MCT oil (typically ≥90 days) with insufficient response
  • You've experienced significant adverse effects from covered alternatives
  • You have medical contraindications to step therapy requirements
  • Your condition is severe enough to warrant immediate specialized therapy

Evidence That Helps

Clinical Documentation:

  • Genetic testing report confirming LC-FAOD diagnosis
  • Medical necessity letter from metabolic specialist
  • Documentation of prior therapy trials and outcomes
  • Evidence of disease severity (hospitalizations, metabolic crises)
  • ICD-10 diagnosis codes (E71.310–E71.318 range)

Supporting Literature: Include peer-reviewed studies demonstrating Dojolvi's efficacy for your specific LC-FAOD subtype. The FDA approval documentation provides strong evidence for medical necessity arguments.

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform ingests denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with each payer's specific requirements, helping patients get prescription drugs approved more efficiently.

Switching Logistics

Provider Coordination

Metabolic Specialist Involvement: Your metabolic specialist or geneticist must coordinate the transition between therapies. Effective management requires a multidisciplinary team including specialists experienced in LC-FAOD care.

Monitoring Requirements: Regular monitoring through fasting blood samples and clinical assessments helps determine when alternative therapy is insufficient and Dojolvi becomes necessary.

Pharmacy Logistics

Specialty Pharmacy Coordination: Cigna manages specialty drugs through Express Scripts/Accredo. Coordinate with your specialty pharmacy to understand prior authorization requirements and appeal processes.

Documentation Timeline: Allow 2-4 weeks for gathering necessary clinical documentation and submitting exception requests. Expedited reviews are available for urgent medical situations.

Re-trying for Dojolvi Later

What to Document During Alternative Trials

Treatment Response:

  • Symptom frequency and severity while on MCT oil
  • Hospitalizations or emergency department visits
  • Laboratory values and metabolic markers
  • Quality of life impacts and functional limitations

Adverse Effects: Document any gastrointestinal intolerance, compliance issues, or other problems with alternative therapies. This strengthens your case for Dojolvi necessity.

Disease Progression: Any worsening of symptoms or development of complications while on standard therapy supports the need for specialized treatment.

Appeals Playbook for Georgia

Internal Appeal Process

Timeline: File within 180 days of denial Review Period: Standard appeals reviewed within 30 days; expedited appeals within 72 hours Documentation: Include all medical records, specialist letters, and peer-reviewed literature

External Review Process

Georgia Department of Insurance Review: If internal appeals fail, you can request external review through the Georgia Department of Insurance within 60 days of your final internal denial letter.

Process:

  1. Submit external review application to Georgia DOI
  2. Independent medical review by specialists in the same field
  3. Decision within 30 business days (expedited: 72 hours for urgent cases)
  4. Binding decision on the insurer

Contact Information: Georgia DOI Consumer Services: 1-800-656-2298

Common Denial Reasons & Fixes

Denial Reason How to Overturn
Lack of genetic confirmation Submit molecular testing results showing pathogenic variants
Insufficient MCT oil trial Document ≥90 days of therapy with response/tolerance data
Missing specialist involvement Obtain consultation note from metabolic geneticist
Step therapy not completed Provide evidence of contraindication or prior failure
Not medically necessary Include peer-reviewed literature and clinical guidelines

FAQ

How long does Cigna prior authorization take in Georgia? Standard PA requests are reviewed within 72 hours. Expedited reviews for urgent situations are completed within 24 hours.

What if Dojolvi is non-formulary on my Cigna plan? You can request a formulary exception with medical necessity documentation. Cigna's formulary exception process allows coverage of non-formulary drugs when medically necessary.

Can I request an expedited appeal in Georgia? Yes, if your condition may seriously jeopardize your health, you can request expedited internal appeals (72 hours) and external review (72 hours).

Does step therapy apply if I've failed MCT oil outside Georgia? Prior treatment history from other states should be accepted. Provide documentation of previous therapy trials and outcomes.

What counts as medical necessity for Dojolvi? Medical necessity includes genetic confirmation of LC-FAOD, inadequate response to standard therapy, or contraindications to covered alternatives.

How much does Dojolvi cost without insurance? Cash prices range from $5,857–$6,365 per 500-mL bottle. Manufacturer assistance programs may be available through Ultragenyx.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. For personalized assistance with insurance appeals, www.counterforcehealth.org provides specialized support for prescription drug coverage denials.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.